V3R 10 Activators are a diverse array of chemical compounds that enhance the functional activity of the V3R 10 protein through various biochemical mechanisms. Capsaicin, for example, stimulates the TRPV1 receptor, leading to calcium influx that can activate downstream proteins including V3R 10, thus potentiating its signaling capacity. Similarly, isoproterenol and forskolin both elevate intracellular cAMP levels through adenylyl cyclase activation, and cAMP directly or via its analog 8-Bromo-cAMP activates PKA, which may phosphorylate and enhance V3R 10. PMA activates PKC, a kinase that can positively influence V3R 10 signaling cascades, whereas ionomycin increases intracellular calcium, a secondary messenger that can activate pathways linked to V3R 10. Bisindolylmaleimide I, by inhibiting PKC, may inadvertently enhance V3R 10 activity by reducing competitive phosphorylation events within its signaling network.
Further modulating V3R 10's activity are compounds that alter the cellular balance of secondary messengers or modulate kinase activity. Sildenafil, through the inhibition of PDE5, raises cAMP and cGMP levels, thus activating kinases like PKA and PKG, which could target V3R 10 or its associated proteins. Verapamil disrupts calcium signaling, and nicotine engages nicotinic acetylcholine receptors, both of which can lead to the modulation of calcium-dependent kinases that affect V3R 10 function. Pure cAMP itself binds to regulatory subunits of PKA, promoting the kinase's activity and the subsequent phosphorylation of proteins including V3R 10, thereby enhancing its activity. Lastly, BAY K8644, by acting as an L-type calcium channel agonist, results in increased calcium levels that can enrich the activity of calcium-dependent signaling pathways, possibly resulting in the upregulation of V3R 10's functional role. Together, these V3R 10 activators act through distinct yet interconnected mechanisms, converging on the enhancement of V3R 10's activity without directly increasing its expression, thereby fine-tuning the cellular processes it governs.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Capsaicin binds to the transient receptor potential vanilloid 1 (TRPV1), which is a receptor V3R 10 is known to interact with. This interaction leads to an influx of calcium ions, enhancing the signaling pathways in which V3R 10 is involved. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that stimulates the adenylyl cyclase pathway, increasing cAMP levels. This elevated cAMP can activate protein kinase A (PKA), which then can phosphorylate target proteins including V3R 10, thereby enhancing its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly activates adenylyl cyclase, increasing intracellular cAMP levels which lead to the activation of PKA. PKA can subsequently phosphorylate V3R 10, leading to its enhanced activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can result in the phosphorylation and activation of V3R 10. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate the activity of proteins that are part of V3R 10's signaling pathway, leading to its enhanced functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which may activate calcium-dependent kinases or phosphatases that modulate V3R 10's function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that can lead to shifts in the signaling balance, potentially enhancing pathways that activate V3R 10 indirectly by reducing inhibitory PKC-mediated phosphorylation events. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil is a calcium channel blocker that alters intracellular calcium levels, potentially affecting calcium-dependent signaling pathways and kinases that could modulate V3R 10's activity. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
cAMP directly activates PKA, leading to the phosphorylation of downstream targets including V3R 10, which enhances its activity. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
BAY K8644 is an L-type calcium channel agonist that increases calcium influx, modulating calcium-dependent signaling pathways and potentially enhancing the activity of V3R 10. |